Mondobiotech, United Therapeutics deal

United Therapeutics' Lung Rx LLC subsidiary received a license to develop and commercialize Mondobiotech's Aviptadil. Lung Rx said it will focus development of the vasoactive intestinal peptide (VIP) ...